Evidence map›Paper›PMID 35991694›Full record

ArticleKidney medicine2022

Education Standards for Pharmacists Providing Comprehensive Medication Management in Outpatient Nephrology Settings.

Joanna Q Hudson, Rebecca Maxson, Erin F Barreto, Katherine Cho, Amanda J Condon, Elizabeth Goswami, Jean Moon, Bruce A Mueller, Thomas D Nolin, Heather Nyman and 2 more

Open access · goldAbstract read
In one paragraph

Article in Kidney medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 12 institutions in 1 country.

Joanna Q HudsonDepartments of Clinical Pharmacy and Translational Science & Medicine (Nephrology), The University of Tennessee Health Science Center, Memphis, Tennessee.
Rebecca MaxsonDepartment of Pharmacy Practice, Auburn University Harrison School of Pharmacy, Birmingham, Alabama.
Erin F BarretoDepartment of Pharmacy, Mayo Clinic, Rochester, Minnesota.
Katherine ChoDepartment of Pharmacy Practice & Clinical Sciences, The University of Texas at El Paso School of Pharmacy, El Paso, Texas.
Amanda J CondonValue-Based Care Team, Kidneylink, Plano, Texas.
Elizabeth GoswamiDepartment of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland.
Jean MoonDepartment of Pharmaceutical Care and Health Systems, University of Minnesota College of Pharmacy, Minneapolis, Minnesota.
Bruce A MuellerDepartment of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan.
Thomas D NolinDepartment of Pharmacy and Therapeutics, and Department of Medicine Renal-Electrolyte Division, University of Pittsburgh Schools of Pharmacy and Medicine, Pittsburgh, Pennsylvania.
Heather NymanDepartment of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah.
A Mary VilayDepartment of Pharmacy Practice and Administrative Sciences, University of New Mexico College of Pharmacy, Albuquerque, New Mexico.
Calvin J MeaneyDepartment of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York.
Auburn University · USJohns Hopkins Hospital · USKidney Associates · USMayo Clinic · USThe University of Texas at El Paso · USUniversity at Buffalo, State University of New York · USUniversity of Michigan–Ann Arbor · USUniversity of Minnesota · USUniversity of New Mexico · USUniversity of Pittsburgh · USUniversity of Tennessee Health Science Center · USUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease is a public health problem that has generated renewed interest due to poor patient outcomes and high cost. The Advancing American Kidney Health initiative aimed to transform kidney care with goals of decreasing the incidence of kidney failure and increasing the number of patients receiving home dialysis or a kidney transplant. New value-based models of kidney care that specify inclusion of pharmacists as part of the kidney care team were developed to help achieve these goals. To support this Advancing American Kidney Health-catalyzed opportunity for pharmacist engagement, the pharmacy workforce must have a fundamental knowledge of the core principles needed to provide comprehensive medication management to address chronic kidney disease and the common comorbid conditions and secondary complications. The Advancing Kidney Health through Optimal Medication Management initiative was created by nephrology pharmacists with the vision that every person with kidney disease receives optimal medication management through team-based care that includes a pharmacist to ensure medications are safe, effective, and convenient. Here, we propose education standards for pharmacists providing care for individuals with kidney disease in the outpatient setting to complement proposed practice standards.

Indexed as

Chronic kidney diseasecomprehensive medication managementeducation standardsnephrologypharmacistpractice standards

Identifiers

PMID35991694
PMCPMC9386092
OpenAlexW4283522845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.